We are live on ! Find out more
AVXL icon

Anavex Life Sciences
AVXL

65 hedge funds and large institutions have $32.6M invested in Anavex Life Sciences in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 14

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

5% more funds holding

Funds holding: 62 → 65 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.87% less ownership

Funds ownership: 23.8% → 22.93% (-0.87%)

21% less capital invested

Capital invested by funds: $41.5M → $32.6M (-$8.91M)

55% less call options, than puts

Call options by funds: $394K | Put options by funds: $869K

Holders
65
Holders Change
+3
Holders Change %
+4.84%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
21
Reduced
14
Closed
7
Calls
$394K
Puts
$869K
Net Calls
-$475K
Net Calls Change
+$3.58M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$305K
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$263K
3
Deutsche Bank
Deutsche Bank
Germany
+$196K
4
Morgan Stanley
Morgan Stanley
New York
+$162K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$110K

Top Sellers

1
PWAM
Park West Asset Management
California
-$632K
2
VF
Virtu Financial
New York
-$102K
3
Russell Investments Group
Russell Investments Group
United Kingdom
-$79K
4
NFA
Nationwide Fund Advisors
Ohio
-$77K
5
TSS
Two Sigma Securities
New York
-$70.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
CG
51
Cutler Group
California
$9K -$57K -14,489 -83%
IWM
52
IHT Wealth Management
Illinois
$9K – – –
AIP
53
Ameritas Investment Partners
Nebraska
$8K – – –
Bank of Montreal
54
Bank of Montreal
Ontario, Canada
$6K – – –
QCG
55
Quadrant Capital Group
Ohio
$5K – – –
Royal Bank of Canada
56
Royal Bank of Canada
Ontario, Canada
$3K -$12.3K -3,126 -75%
MAM
57
Meeder Asset Management
Ohio
$3K +$2.83K +719 +371%
BL
58
Balentine LLC
Georgia
$1K – – –
SPIA
59
Steward Partners Investment Advisory
New York
$1K – – –
TIM
60
Tortoise Investment Management
New York
$1K – – –
AF
61
Advisornet Financial
Minnesota
$1K +$787 +200 New
VF
62
Virtu Financial
New York
– -$102K -24,671 Closed
Russell Investments Group
63
Russell Investments Group
United Kingdom
– -$79K -19,196 Closed
NFA
64
Nationwide Fund Advisors
Ohio
– -$77K -18,498 Closed
ARTA
65
A.R.T. Advisors
New York
– -$63K -15,289 Closed
Balyasny Asset Management
66
Balyasny Asset Management
Illinois
– -$61K -14,616 Closed
SO
67
STRS Ohio
Ohio
– -$39K -9,600 Closed
ASN
68
Advisory Services Network
Georgia
– -$2K -454 Closed
FFG
69
Ford Financial Group
California
– +$98 +25 New
CIBC Private Wealth Group
70
CIBC Private Wealth Group
Georgia
– +$492 +125 New
CA
71
Calton & Associates
Florida
– +$984 +250 New
1 2
3

AVXL Hedge Fund Activity: Q4 2017 in Review

65 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q4 2017, worth a combined $32.6M — down 21% from $41.5M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new AVXL positions and 7 closed out — a net gain of 3 holders — while 21 added to existing stakes and 14 trimmed.

The largest buyer was Vanguard Group, adding an estimated $305K. The largest seller was Park West Asset Management, cutting an estimated $632K.

  • 65 institutional investors held Anavex Life Sciences (AVXL) as of Q4 2017, up from 62 in Q3 2017.
  • Funds reported $32.6M of Anavex Life Sciences stock for Q4 2017, down 21% quarter-over-quarter.
  • 10 funds opened new Anavex Life Sciences positions in Q4 2017 and 7 closed out, a net change of +3 holders.
  • The largest Anavex Life Sciences buyer in Q4 2017 was Vanguard Group, an estimated $305K added.
  • The largest Anavex Life Sciences seller in Q4 2017 was Park West Asset Management, an estimated $632K sold.

Based on aggregated 13F filings for Q4 2017.